tirzepatide weight loss trial once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURPASS to SURMOUNT: The Tirzepatide

"This is kind of thinking more about long-term impacts [of weight] more than just the short term of achieving pregnancy." The bottom line: There remains much we dont know about the safety or potential impact of semaglutide and tirzepatide

What are the practical implications for treating diabetes in light of recent evidence

doi:10.1111/cts.13142 212

Negative reviewers describe persistent inconsistency or complete lack of effect

Please consult with your physician or qualified healthcare professional for guidance on drugs, medical conditions, or treatments

This is not a theoretical claim every batch has a specific Certificate of Analysis documenting the HPLC trace and mass spectrometry data